Although there are few descriptive studies of NE inhibitors in humans with bacterial pneumonia, a previous study suggested that early administration of NE inhibitor may improve acute lung injury and survival rate in severe pneumonia (18). Here, ELANE is linked to susceptibility to pneumonia measurement.